Ahammune Biosciences Secures $5M for Vitiligo Trials
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
- Latest
- Trending
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
State Farm and Berkshire Hathaway boost their fossil fuel investments, diverging from industry trends towards ESG policies.
Michael Saylor supports BlackRock's bullish stance on Bitcoin, highlighting its appeal as a global, decentralized asset.
Bitcoin ETFs see $136M inflows, Ethereum ETFs rebound with $62.5M, reinforcing investor interest in digital assets.
Meta Connect 2024 highlights Project Orion AR glasses, AI, and metaverse innovations. Mark Zuckerberg's keynote sets the stage.
TrueCoin settles with SEC for $700K over misrepresentation and failures in stablecoin practices, highlighting regulatory challenges.
Mark Cuban criticizes SEC Chair Gary Gensler, calls him a 'blight' on crypto community, urges for less regulation.
Ethereum ETFs saw a $79.2M outflow, marking their largest since July. Is declining demand impacting ETH's market position?
Explore market signals for gold and US indices on September 25, 2024, with key insights from social media trends.
Crypto scams are costing Maryland residents millions. FBI warns against online investment opportunities from unknown sources.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.